Clinical Trials Directory

Trials / Completed

CompletedNCT04697862

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil

Hemodynamic Effects of Acute Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension: Single-center Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To study the effect of acute normobaric hypoxia during exercise in patients with pulmonary hypertension with/without Sildenafil

Conditions

Interventions

TypeNameDescription
OTHERNormobaric hypoxia (FiO2 15%) under SildenafilInhalation of deoxygenated air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour. given by a facemask, first at rest and then during exercise under Sildenafil.
OTHERNormobaric hypoxia (FiO2 15%)Inhalation of deoxygenated air through an altitude simulator ("Altitrainer"), for approx. 1/2 hour given by a facemask, first at rest and then during exercise.

Timeline

Start date
2021-02-01
Primary completion
2023-05-31
Completion
2023-05-31
First posted
2021-01-06
Last updated
2023-06-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04697862. Inclusion in this directory is not an endorsement.

Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil (NCT04697862) · Clinical Trials Directory